Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Anticancer Research|December 31, 1997
Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell lineG Köhler, H Veelken, F Rosenthal, et al.Human Gene Therapy|October 1, 1996
Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivoH Veelken, D Re, P Kulmburg, et al.Leukemia|August 2, 2016
The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemiaM Qorraj, H Bruns, M Böttcher, et al.Human Gene Therapy|October 1, 1994
Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapyH Veelken, H Jesuiter, A Mackensen, et al.The Journal of Clinical Investigation|April 1, 1994
Direct evidence to support the immunosurveillance concept in a human regressive melanomaA Mackensen, G Carcelain, S Viel, et al.Stem Cells (Dayton, Ohio)|September 30, 2000
Cytokine gene transfer in cancer therapyL Cao, P Kulmburg, H Veelken, et al.European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancerF Otto, P Schmid, A Mackensen, et al.Journal of Autoimmunity|December 1, 1993
In-situ preferential usage of V alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoidH Michalaki, S Roman-Roman, J F Nicolas, et al.Leukemia|May 22, 2021
CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activityA Stoll, H Bruns, M Fuchs, et al.Oncology Reports|March 15, 2014
Nilotinib combined with interleukin-2 mediates antitumor and immunological effects in a B16 melanoma modelK Geisler, A Reischer, I Kroeger, et al.Pageof 6